B of A Securities Maintains Buy on Tyra Biosciences, Raises Price Target to $42
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
B of A Securities analyst Geoff Meacham maintains Tyra Biosciences (NASDAQ:TYRA) with a Buy and raises the price target from $37 to $42.
B of A Securities analyst Geoff Meacham maintains Tyra Biosciences (NASDAQ:TYRA) with a Buy and raises the price target from $37 to $42.